Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
SHOCKING: Most Medical Reviewers Paid by Big Pharma
My office has banned pharmaceutical representatives from coming into our office. Moreover, my hospital doesn't allow them entry. It was truly surprising to discover that a significant number of doctors conducting peer reviews for major medical…
Labour's big pharma slimming injection to 'protect the NHS'
Labour joined forces with big pharma this week to announce “the first real world trial” of Eli Lilly's slimming injections tirzepatide on UK citizens. Hold me back, but this is odious on so many levels that it's hard to know where to…
PE appetite for pharma services shows with THL paying over $750M for Red Nucleus
Thomas H. Lee Partners acquired life sciences communications firm Red Nucleus from Riverside for $750 million-plus, sources familiar with the deal tell Axios. Why it matters: Private equity's appetite for pharma services assets seems to be getting…
BARR: Are Mark Cuban, Big Pharma And VP Harris Plotting To Raise Drug Prices?
Former “Shark Tank” star Mark Cuban likes to position himself as a humanitarian. But it turns out he might be just another well-connected celebrity using his high-profile political connections to rig the marketplace in his favor. The…
Jagsonpal Pharma share price: Jagsonpal Pharma up 7% as co to consider Q2 results, stock-split on Oct 23
Jagsonpal Pharma share price: Shares of Jagsonpal Pharmaceuticals Limited (JPL) were in demand on Thursday, October 17, 2024, as the scrip rallied up to 6.59 per cent to hit an intraday high of Rs 479.25 per share. The uptick in Jagsonpal Pharma…
Labour plans will make Big Pharma happy but ignore problem's roots
Eli Lilly will invest £279 million in a five-year clinical trial on 3000 overweight and unemployed people in the low-tax, low-regulation Manchester Special Enterprise Zone (SEZ). READ MORE: Unemployed to be given weight-loss jags to 'get them…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0703 GMT – Sartorius's third-quarter results are solid, compared with the company's recent history and…
Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds (NYSE:ELV)
Elevance Health's Q3 earnings report led to a 14% stock price drop due to increased benefit expense ratio and declining EPS. The health insurance industry faces challenges, particularly in Medicare Advantage and Medicaid, affecting profitability…
The Billionaire Behind Groupon Is Making A Fortune In An Industry He Swore He'd Never Enter
W alking through health technology firm Tempus AI's midtown Manhattan office, Eric Lefkofsky brushes past stick-straight fronds of snake plants in neatly arranged planter boxes and employees chatting over lunch in the open-floor-plan space which…
If Based on Merit, the FTC Should Lose PBM Suit
FTC Chairwoman Lina Khan, with her fellow Democratic Commissioners, recently filed a suit against the leading PBMs in an effort to undermine, or even prohibit, their use of rebates to secure savings in the prescription drug supply chain. In a…
Simplismart supercharges AI performance with personalized, software-optimized inference engine
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Enterprises are all in on AI. They want their models to run in production environments smoothly and with as high…
Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies
Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies Paris (France), 17 October, 2024 – Iktos, a leader in Artificial Intelligence (AI) and Robotics…
Weight-loss drugs may reduce opioid and alcohol abuse by up to 50%, study finds
Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer greater benefits than just weight and diabetes…
Johnson & Johnson Q3 Earnings Review: Nicely Poised For Steady Growth (Upgrade) (JNJ)
Johnson & Johnson reported solid Q3 revenues of $22.5bn, up 5.2% YoY, despite a 34% drop in EPS due to IPRD and litigation impacts. The innovative medicines division, led by Darzalex and Tremfya, shows strong growth potential, with management…
Kamala Harris must stay strong on Biden-era corporate enforcement
Since first jumping into the race for president five years ago, Kamala Harris has run as a tough prosecutor and on the promise of an America where “no one is above the law.” Yet, at dizzying pace, big donors and Washington lobbyists…
Receive a Daily briefing on Pharma Industry News
Get Started